325 related articles for article (PubMed ID: 1092714)
1. Studies with human leukocyte lysosomes. Evidence for antilysosome antibodies in lupus erythematosus and for the presence of lysosomal antigen in inflammatory diseases.
Bell DA; Thiem PA; Vaughan JH; Leddy JP
J Clin Invest; 1975 Feb; 55(2):256-68. PubMed ID: 1092714
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
Bruneau C; Bonin H
Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
[TBL] [Abstract][Full Text] [Related]
4. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
Rauch J; Massicotte H; Tannenbaum H
J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
[TBL] [Abstract][Full Text] [Related]
5. The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseases.
March RE; Reeback JS; Holborow EJ; Jones VE; Jacoby RK
Clin Exp Immunol; 1982 Jun; 48(3):555-60. PubMed ID: 6981473
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
[TBL] [Abstract][Full Text] [Related]
7. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
[TBL] [Abstract][Full Text] [Related]
8. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
Cook AD; Rowley MJ; Wines BD; Mackay IR
J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
[TBL] [Abstract][Full Text] [Related]
10. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
11. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera.
Mattioli M; Reichlin M
J Immunol; 1971 Nov; 107(5):1281-90. PubMed ID: 4330162
[No Abstract] [Full Text] [Related]
13. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases.
Cook AD; Mackay IR; Cicuttini FM; Rowley MJ
J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865
[TBL] [Abstract][Full Text] [Related]
14. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
Baatrup G; Petersen I; Jensenius JC; Svehag SE
Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
[TBL] [Abstract][Full Text] [Related]
15. Expression in systemic lupus erythematosus of an idiotype common to DNA-binding and nonbinding monoclonal antibodies produced by normal human lymphoid cells.
Cairns E; Massicotte H; Bell DA
J Clin Invest; 1989 Mar; 83(3):1002-9. PubMed ID: 2493481
[TBL] [Abstract][Full Text] [Related]
16. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
[TBL] [Abstract][Full Text] [Related]
17. Studies of circulating immune complexes in ankylosing spondylitis.
Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
[TBL] [Abstract][Full Text] [Related]
18. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
Anderson CL; Stillman WS
J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
20. The ananti-alpha-actinin test completes ananti-DNA determination in systemic lupus erythematosus.
Croquefer S; Renaudineau Y; Jousse S; Gueguen P; Ansart S; Saraux A; Youinou P
Ann N Y Acad Sci; 2005 Jun; 1050():170-5. PubMed ID: 16014531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
